Guardant Health (GH) Stock Analysis
This is a peer-relative look at Guardant Health (GH): its performance, risk, profitability, growth, financial strength, dividend, and valuation are each measured against its Health Care Equipment & Services peers, so every number reads in context rather than in isolation.
Company Profile
| Profile Item | GH |
|---|---|
| Name | Guardant Health, Inc. |
| Country/Region | United States |
| GICS Sector | Health Care |
| GICS Industry Group | Health Care Equipment & Services |
| GICS Industry | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Services |
| Market Capitalization | 20.41 billion USD |
| Currency | USD |
| Exchange | Nasdaq |
| Listing Date | October 4, 2018 |
| Security Type | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | Current stock: GH | Industry group median |
|---|---|---|
| Total Return (1Y) | 66.53% | 21.53% |
| Total Return (3Y, Annualized) | 92.76% | 9.81% |
| Total Return (5Y, Annualized) | 8.36% | -2.76% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | Current stock: GH | Industry group median |
|---|---|---|
| Volatility (1Y, Annualized) | 53.23% | 50.93% |
| Beta (5Y) | 1.69 | 0.85 |
| Max Drawdown (5Y) | -85.09% | -70.34% |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | Current stock: GH | Industry group median |
|---|---|---|
| Sharpe Ratio (1Y) | 1.17 | 0.34 |
| Sortino Ratio (1Y) | 1.84 | 0.54 |
Profitability
ROE (TTM)
No usable ROE is available for Guardant Health (GH) this period, so the shareholder-equity return read is skipped.
GH
Health Care Equipment & Services industry group
--
Group distribution
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
- GH
- --
Largest peers
- ISRG
- 17.93%
- SYK
- 16.02%
- UNH
- 15.77%
- MDT
- 10.65%
- ABT
- 9.14%
- GH
- --
- MCK
- --
Net Margin (TTM)
Guardant Health (GH) has negative net margin of -37.93%. The trailing period ended in a net loss, so the bottom-line conversion read is a warning rather than a profitability strength.
GH
Health Care Equipment & Services industry group
-37.93%
Group distribution
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
- GH
- -37.93%
Largest peers
- ISRG
- 25.54%
- MDT
- 13.93%
- SYK
- 13.78%
- ABT
- 9.75%
- UNH
- 3.53%
- MCK
- 1.12%
- GH
- -37.93%
Operating Margin (TTM)
Guardant Health (GH) has negative operating margin of -37.06%. Core operations were loss-making before interest and taxes over the trailing period.
GH
Health Care Equipment & Services industry group
-37.06%
Group distribution
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
- GH
- -37.06%
Largest peers
- ISRG
- 33.29%
- SYK
- 22.96%
- MDT
- 19.33%
- ABT
- 11.66%
- UNH
- 5.82%
- MCK
- 1.48%
- GH
- -37.06%
Profitability Metrics
| Metric | Current stock: GH | Industry group median |
|---|---|---|
| ROE (TTM) | -- | 5.45% |
| ROA (TTM) | -19.92% | 3.17% |
| Net Margin (TTM) | -37.93% | 2.18% |
| Operating Margin (TTM) | -37.06% | 6.81% |
| Gross Margin (TTM) | 65.19% | 55.21% |
Growth
Revenue Growth
Guardant Health (GH) grew revenue 32.88%, in the upper peer quartile. The top line is expanding faster than at most industry peers, which points to share gains or stronger pricing.
EPS Growth
No usable EPS growth is available for Guardant Health (GH) this period, so the earnings-momentum read is skipped.
Growth Metrics
| Metric | Current stock: GH | Industry group median |
|---|---|---|
| Revenue Growth (YoY) | 32.88% | 11.55% |
| Revenue Growth (3Y CAGR) | 29.75% | 10.83% |
| EPS Growth (YoY) | -- | 4.88% |
| EPS Growth (3Y CAGR) | -- | 14.59% |
Financial Strength
Current Ratio (MRQ)
Guardant Health (GH) has current ratio of 3.60, in the healthier middle range for its industry. The short-term asset cushion looks balanced relative to peers rather than stretched thin.
GH
Health Care Equipment & Services industry group
3.60
Group distribution
- Max
- 7.59
- Q3
- 4.00
- GH
- 3.60
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Largest peers
- GH
- 3.60
- ISRG
- 3.33
- SYK
- 2.18
- MDT
- 2.07
- ABT
- 1.46
- MCK
- 0.90
- UNH
- 0.74
Debt / Equity (MRQ)
No usable debt-to-equity ratio is available for Guardant Health (GH) this period, so the balance-sheet leverage read is skipped.
GH
Health Care Equipment & Services industry group
--
Group distribution
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
- GH
- --
Largest peers
- UNH
- 0.70
- SYK
- 0.66
- ABT
- 0.61
- MDT
- 0.55
- GH
- --
- ISRG
- --
- MCK
- --
Financial Strength Metrics
| Metric | Current stock: GH | Industry group median |
|---|---|---|
| Current Ratio (MRQ) | 3.60 | 1.98 |
| Debt / Equity (MRQ) | -- | 0.58 |
| Net Debt / EBITDA | -- | 2.04 |
Dividends
Dividend Yield (TTM)
Guardant Health (GH) pays no dividend, leaving dividend yield at 0.00% this period. Shareholders may still receive value through reinvestment or buybacks, but there is no dividend income to compare here.
GH
Health Care Equipment & Services industry group
0.00%
Group distribution
- GH
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Largest peers
- MDT
- 2.72%
- UNH
- 2.29%
- ABT
- 2.22%
- SYK
- 1.05%
- MCK
- 0.32%
- GH
- 0.00%
- ISRG
- 0.00%
Dividend Payout Ratio (TTM)
Guardant Health (GH) paid no earnings out as dividends this period, leaving payout ratio at 0.00%. There is no dividend payout to size against earnings.
GH
Health Care Equipment & Services industry group
0.00%
Group distribution
- GH
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Largest peers
- ABT
- 92.54%
- MDT
- 70.02%
- UNH
- 51.71%
- SYK
- 37.49%
- MCK
- 8.77%
- GH
- 0.00%
- ISRG
- 0.00%
Dividend Metrics
| Metric | Current stock: GH | Industry group median |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
No usable P/E ratio is available for Guardant Health (GH) this period, so the trailing-earnings valuation read is skipped.
GH
Health Care Equipment & Services industry group
--
Group distribution
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- GH
- --
Largest peers
- ISRG
- 54.75
- ABT
- 41.02
- SYK
- 34.70
- MCK
- 27.36
- MDT
- 25.01
- UNH
- 22.50
- GH
- --
P/S Ratio (TTM)
Guardant Health (GH) trades at 15.96 on P/S ratio, above the industry benchmark range. The stock is being valued at an unusually rich price per dollar of trailing revenue.
GH
Health Care Equipment & Services industry group
15.96
Group distribution
- GH
- 15.96
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
Largest peers
- GH
- 15.96
- ISRG
- 13.82
- SYK
- 4.72
- ABT
- 3.95
- MDT
- 3.47
- UNH
- 0.78
- MCK
- 0.29
P/B Ratio (MRQ)
Guardant Health (GH) has negative P/B ratio of -73.67, which means reported book equity is negative. Price-to-book breaks down in this situation and should not be used as a valuation signal.
GH
Health Care Equipment & Services industry group
-73.67
Group distribution
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
- GH
- -73.67
Largest peers
- ISRG
- 9.82
- SYK
- 5.29
- ABT
- 3.73
- UNH
- 3.60
- MDT
- 2.59
- MCK
- -30.85
- GH
- -73.67
Valuation Metrics
| Metric | Current stock: GH | Industry group median |
|---|---|---|
| P/E Ratio (TTM) | -- | 29.93 |
| P/S Ratio (TTM) | 15.96 | 2.13 |
| P/B Ratio (MRQ) | -73.67 | 3.00 |
| Free Cash Flow Yield (TTM) | -0.30% | 3.50% |